LWLIVING WITH T1D
Living With T1D/November 8, 2026/3 min read

When Pump Supplies Run Short: What One Case Teaches Us About DKA Risk

A case report shows how reusing single-use insulin pump cartridges during a supply shortage led to device failure and diabetic ketoacidosis, even in someone using an advanced automated system. The story underscores critical gaps in pump safety.

Research summaryPubMed indexed literature

Evidence label explains the kind of source behind this article (for example peer-reviewed literature vs community video). It is not medical advice.

living with t1dmental healthtechnologysupport

Key takeaways

  • Diabetic ketoacidosis can occur in people using modern closed-loop insulin pumps if the device itself malfunctions, even when blood sugar readings seem stable
  • Single-use pump supplies are designed for one use only; reusing them—even out of necessity—can cause structural damage that automated systems may not detect
  • Hybrid closed-loop systems are powerful tools, but they cannot catch every mechanical failure in the infusion device itself
  • Supply disruptions create real safety risks; planning ahead and exploring safe alternatives is crucial for people who depend on pump therapy

A Serious Complication Despite Advanced Technology

A 45-year-old woman using one of the most sophisticated insulin delivery systems available—an advanced hybrid closed-loop pump—was hospitalized with mild diabetic ketoacidosis (DKA). On the surface, this was surprising. Modern closed-loop systems are designed to prevent exactly this kind of emergency by automatically adjusting insulin delivery based on continuous glucose monitoring data.

Yet it happened. And the culprit wasn't a software glitch or a sensor error. It was a broken piece of equipment—and a difficult choice born from supply shortages.

How a Reused Cartridge Caused Device Failure

After the patient was treated and recovered, doctors reviewed her glucose monitor records and insulin pump logs. They found persistent high blood sugar readings that the system had missed. The investigation revealed the root cause: the insulin cartridge—the small reservoir that holds insulin—had physically deteriorated.

The cartridge was not new. It was a single-use component that had been reused multiple times. In the context of a shortage of original supplies, the patient and her care team had made the difficult decision to extend its use. Over time, structural damage accumulated. The cartridge began to malfunction, preventing insulin from being delivered properly.

The closed-loop system, sophisticated as it is, could not detect this mechanical failure. From the pump's perspective, it was doing its job. But the insulin simply wasn't getting through.

What This Case Reveals About Pump Safety

This case illustrates three important limitations in pump therapy, even with the most advanced systems:

First, automated insulin systems are only as good as their hardware. A closed-loop algorithm cannot fix a broken cartridge or infusion set. Second, these systems have blind spots—they monitor glucose levels and respond to them, but they may not immediately detect mechanical problems in the delivery device itself. Third, the design of pump supplies matters enormously. Single-use components exist for good reasons: they maintain sterility, structural integrity, and reliable function.

When supplies run short and reuse becomes necessary, safety risks emerge that the technology itself cannot prevent.

Why Supply Access Matters

This case raises an urgent question: What happens when people who depend on pump therapy cannot access the supplies they need? Whether due to cost, geography, or shortage, gaps in supply force difficult choices.

The patient in this story faced that reality. She and her medical team did what seemed reasonable under constrained circumstances. Yet it led to a serious complication that could have been far worse.

The takeaway isn't blame—it's recognition. Supply disruptions are not just inconvenient; they can directly threaten safety. For people using insulin pumps, reliable access to genuine, single-use supplies is as important as the pump technology itself.

Moving Forward: Questions Worth Asking

This case highlights the need for safe strategies when supply disruptions occur. People using pump therapy, their care teams, and healthcare systems should consider: What are the backup plans if supplies become scarce? Are there alternatives to reuse that maintain safety? How can shortages be anticipated and managed?

Insulin pump technology has advanced dramatically. The systems that manage diabetes today are far more capable than those of a decade ago. But technology is only part of the equation. Reliable supplies, access, and support are just as essential—and sometimes overlooked—components of safe pump therapy.

Evidence label

Source: Endocrinologia, diabetes y nutricion. Evidence type: PubMed indexed literature. Type1Cure is an information and intelligence hub, not a medical advice service. This article summarizes published research and does not provide diagnosis, treatment, or personal medical guidance. Always talk to your own care team before changing anything about your Type 1 diabetes management.

Type1Cure is an information and intelligence hub, not a medical advice service. This article summarizes published research and does not provide diagnosis, treatment, or personal medical guidance. Always talk to your own care team before changing anything about your Type 1 diabetes management.

From Type1Cure

Our own writing on the same ground.

More evidence-labeled coverage across the Type1Cure library.